Improving Lung Function in COPD With Indacaterol/Glycoptrrolate Inhaler
Multiple studies presented at ATS 2017 indicated that indacaterol/glycoptrrolate inhaler therapy results in clinically significant improvements in COPD-related quality of life.
Multiple studies presented at ATS 2017 indicated that indacaterol/glycoptrrolate inhaler therapy results in clinically significant improvements in COPD-related quality of life.
The American Association for Thoracic Surgery released guidelines for the management of empyema.
Sunovion announces Utibron Neohaler, an inhalation powder for the long term maintenance treatment of airflow obstruction in COPD patients.